SR

Santosh Raghunathrao Bedre

Active Director Director DIN 10549121
DIN 10549121 First appointment Mar 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Santosh Raghunathrao Bedre

Data last updated:

Santosh Raghunathrao Bedre is a Director at Arts Diagnostics Private Limited (since 2024). The company operates in Healthcare.

DIN 10549121
Primary Designation Director
Industry Healthcare
First Appointment 14 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arts Diagnostics Private Limited U86905PN2024PTC229144
Director14 Mar 20242024Active

Board colleagues of Santosh Raghunathrao Bedre

Directorship timeline

Open interactive timeline →
Arts Diagnostics Private Limited
Premium access

Shareholding and investment profile for Santosh Raghunathrao Bedre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santosh Raghunathrao Bedre

Santosh Raghunathrao Bedre currently holds 1 directorship: Arts Diagnostics Private Limited (Director, since 14 Mar 2024).

Santosh Raghunathrao Bedre was first appointed on 14 Mar 2024 as Director at Arts Diagnostics Private Limited.

The current boards of Santosh Raghunathrao Bedre's companies include Amol Nagesh Shinde (Arts Diagnostics Private Limited), Ravindra Balasaheb Temgire (Arts Diagnostics Private Limited), Smita Ravindra Temgire (Arts Diagnostics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available